Related Experiment Video
Updated: May 31, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Post-natal corticosteroids are associated with reduced expiratory flows in children born very preterm
Lucia J Smith1, Peter P van Asperen, Karen O McKay
1Department of Respiratory Medicine, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
Insights
Corticosteroids given to premature infants did not impact school-age lung function, but postnatal steroids were linked to reduced airflow. Further research is needed on postnatal corticosteroid effects on lung development.
Area of Science:
- Pediatric Pulmonology
- Neonatal Medicine
- Respiratory Medicine
Background:
- Infants born very prematurely often receive corticosteroids to reduce the risk of bronchopulmonary dysplasia (BPD).
- The long-term effects of these treatments on school-age lung function remain unclear.
- Understanding these impacts is crucial for optimizing respiratory care in preterm infants.
Purpose of the Study:
- To investigate the long-term impact of corticosteroid treatment on school-age lung function in very preterm infants.
- To determine if a BPD diagnosis or antenatal/postnatal corticosteroid exposure affects lung function at approximately 10 years of age.
Main Methods:
- A cross-sectional study included 105 children born at a mean gestation of 27 weeks.
- Lung function was assessed at a mean age of 10 years using spirometry.
- Corticosteroid exposure (antenatal and postnatal) was documented from medical records.
Main Results:
- Children with BPD showed no significant difference in spirometry compared to those without BPD.
- Antenatal corticosteroid treatment alone did not adversely affect lung airflow.
- Children who received postnatal corticosteroids exhibited significantly lower expiratory airflow (FEV1 and FEF25%-75%) compared to those who did not.
Conclusions:
- A BPD diagnosis did not predict reduced lung function in middle childhood.
- Postnatal corticosteroid exposure in preterm infants was associated with reduced expiratory airflow at school age.
- While postnatal corticosteroids may indicate lung disease severity, their direct impact on lung development warrants further investigation.
Aim:
Infants born very prematurely often received corticosteroids to minimise the risk of developing bronchopulmonary dysplasia (BPD) but their long term impact on lung function at school age is unclear.
Methods:
A cross-sectional study of 105 children [mean gestation of 27 weeks] was undertaken. Lung function assessments were conducted at a mean age of 10 years according to standard criteria. Corticosteroid dose was obtained from the medical record.
Results:
Spirometry in the BPD group was not significantly different to the non-BPD group, mean per-cent predicted (95% confidence interval) forced expiratory volume in 1 s (FEV1) 83% (79, 87) versus 86% (83, 90), FEF25%-75% 67% (60, 73) versus 75% (69, 81). Antenatal steroid treatment alone did not adversely affect airflow FEV1, 88% (84.92) versus 90% (82.97), and forced expiratory flow (FEF)25%-75%, 75% (69.81) versus 87% (70.104). Children who received post-natal corticosteroids had significantly lower flows than those who did not (FEV1 82% (78.85) vs. 88% (85.92), P = 0.006; FEF25%-75% 65% (59.71) vs. 78% (72.84), P = 0.003). Regression analysis revealed days on oxygen and days ventilated were statistically significant but weak predictors of airflow at 10 years of age.
Conclusions:
A diagnosis of BPD did not predict reduced spirometry in middle childhood. Children who received post-natal corticosteroids as preterm infants had reduced expiratory flows compared with those who did not. While post-natal corticosteroids may be a marker of severity of lung disease, the potential of post-natal corticosteroids to influence lung development requires further investigation.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Breathing
Pulmonary Cycle: Exhalation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features